Cortisol, depression and reduced cortico-cortical cross-talk in Cushing's syndrome

Journal of Endocrinological Investigation

Volumn 27, Issue 7, 2004, Pages 683-686

  Schutter, D J L G ^a   van Honk, J ^a   de Haan, E H F ^a   van Huffelen, A C ^b   Koppeschar, H P F ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cortico cortical cross talk; Cortisol; Cushing's syndrome; Depression; EEG

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; HYDROCORTISONE;

ADULT; ARTICLE; CASE REPORT; CUSHING SYNDROME; DEPRESSION; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; HYPERCORTISOLISM; OPTICAL COHERENCE TOMOGRAPHY; PROVOCATION TEST; QUANTITATIVE DIAGNOSIS; RATING SCALE;

EID: 5444250434     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347504     Document Type: Article

References (27)

1. Boscaro M, Barzon L, Fallo F, Sonino N. Cushing's syndrome. Lancet 2001, 357: 783-91.
2. Gold PW, Drevets WC, Charney DS. New insights into the role of cortisol and the glucocorticoid receptor in severe depression. Biol Psychiatry 2002, 52: 381-5.
3. Nieman LK, Chrousos GP, Kellner C, et al. Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. J Clin Endocrinol Metab 1985, 61: 536-40.
4. Schutter DJLG, Van Honk J, Koppeschaar HPF, Kahn RS. Cortisol and reduced interhemispheric coupling between the left prefrontal and the right parietal cortex. J. Neuropsychiatry Clin Neurosci 2002, 14: 89-90.
5. Nunez PL, Srinivasan R, Westdorp AF, et al. EEG coherency I: statistics, reference electrode, volume conduction, Laplacians, cortical imaging, and interpretation at multiple levels. Electroencephalogr Clin Neurophysiol 1997, 103: 499-515.
6. Leuchter AF, Cook IA, Uijtdehaage SH, et al. Brain structure and function and the outcomes of treatment for depression. J Clin Psychiatry 1998, 58: 22-31.
7. Schutter DJLG, Peper JS, Koppeschaar HPF, Kahn RS, Van Houk J. Administration of testosterone increases functional connectivity in a cortico-cortical depression circuit. J Neuropsychiatry Clin Neurosci, in press.
8. Roemer RA, Shagass C, Dubin W, Jaffe R, Katz R. Relationship between pretreatment electroencephalographic measures and subsequent response to electroconvulsive therapy: A preliminary study. Neuropsychobiology 1990, 24: 121-4.
9. Van der Lely AJ, Foeken K, Van der Mast RC, Lamberts SWJ. Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486). Ann Int Med 1991, 114: 143-4.
10. Murphy BEP, Filipini D, Ghadirian AM. Possible use of glucocorticoid antagonists in the treatment of major depression: preliminary results using RU486. J Psychiatry Neurosci 1993, 18: 209-13.
11. Belanoff JK, Rothschild AJ, Cassidy F, et al. An open label trial of C-1073 (Mifepristone) for psychotic major depression. Biol Psychiatry 2002, 52: 386-92.
12. De Kloet ER, Vreugdenhil E, Oitzl MS, Joëls M. Brain corticosteroid receptor balance in health and disease. Endoc Rev 1998, 19: 269-301.
13. Mosmose KJ, Kjellberg RN, Kliman B. High incidence of cortical atrophy of the cerebral and cerebellar hemispheres in Cushing's syndrome. Radiology 1971, 99: 341-8.
14. Simmons NE, Do HM, Lipper MH, Laws Jr ER. Cerebral atrophy in Cushing's syndrome. Surg Neurol 2000, 53: 72-6.
15. Cook IA, Leuchter AF, Morgan ML, et al. Cognitive and physiologic correlates of subclinical structural brain syndrome in elderly healthy control subjects. Arch Neurol 2002, 59: 1612-20.
16. Bourdeau I, Bard C, Noel B, et al. Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 2002, 87: 1949-54.
17. Schutter DJLG, d'Alfonso AA, Van Honk J. Counterintuitive antidepressant properties of slow rTMS over the left frontal cortex: A possible mechanism. J Neuropsychiatry Clin Neurosci 2003, 15: 243-4.
18. George MS, Nahas Z, Kozel FA, et al. Mechanisms and state of the art of transcranial magnetic stimulation. J ECT 2002, 18: 170-81.
19. Rosenberg PB, Mehndiratta RB, Mehndiratta YP, Wamer A, Rosse RB, Balish M. Repetitive transcranial magnetic stimulation treatments of comorbid posttraumatic stress disorder and major depression. J Neuropsychiatry Clin Neurosci 2002, 14: 270-6.
20. Jing H, Takigawa M. Observation of EEG coherence after repetitive transcranial magnetic stimulation. Clin Neurophysiol 2001, 111: 1620-31.
21. Van Honk J, Schutter DJLG, Putman P, De Haan EHF, d'Alfonso AAL. Reductions in phenomenological, physiological and attentional indices of depressive mood after 2 Hz rTMS over the right parietal cortex in healthy human subjects. Psychiatry Res 2003, 120: 95-101.
22. Nicolson N, Storms C, Ponds R, Sulon J. Salivary cortisol levels and stress reactivity in human aging. J Gerontol A Biol Sci Med Sci 1997, 52: 68-75.
23. Duffy FH, McAnulty GB, Albert MS. Effect of age upon interhemispheric EEG coherence in normal adults. Neurobiol Aging 1996, 17: 587-99.
24. Lupien S, Lecours AR, Lussier I, Schwartz G, Nair NPV, Meaney MJ. Basal cortisol levels and cognitive deficits in human aging. J Neurosci 1994, 14: 2893-903.
25. Lupien S, Lecours AR, Schwartz G, et al. Longitudinal study of basal cortisol levels in healthy elderly subjects: evidence for subgroups. Neurobiol Aging 1996, 17: 95-105.
26. Sharma M, Palacios-Bois J, Schwartz G, et al. Circadian rhythms of melatonin and cortisol in aging. Biol Psychiatry 1989, 25: 305-19.
27. Dorn LD, Burgess ES, Friedman TC, Dubbert B, Gold PW, Chrousos GP. The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 1997, 82: 912-9.